Cognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders

References

• Aharonovich, E., Nunes, E., & Hasin, D. (2003). Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug and Alcohol Dependence, 71(2), 207–211. doi:10.1016/S0376-8716(03)00092-9
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: American Psychiatric Association.
   Google Scholar
• Anderson, A. L., Li, S. H., Biswas, K., McSherry, F., Holmes, T., Iturriaga, E., Elkashef, A. M. (2012). Modafinil for the treatment of methamphetamine dependence. Drug and Alcohol Dependence, 120(1–3), 135–141. doi:10.1016/j.drugalcdep.2011.07.007
   PubMed Web of Science ®Google Scholar
• Anderson, A. L., Reid, M. S., Li, S. H., Holmes, T., Shemanski, L., Slee, A., … Elkashef, A. M. (2009). Modafinil for the treatment of cocaine dependence. Drug and Alcohol Dependence, 104(1–2), 133–139. doi:10.1016/j.drugalcdep.2009.04.015
   PubMed Web of Science ®Google Scholar
• Arnone, D., McIntosh, A. M., Ebmeier, K. P., Munafo, M. R., & Anderson, I. M. (2012). Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses. European Neuropsychopharmacology, 22(1), 1–16. doi:10.1016/j.euroneuro.2011.05.003
   PubMed Web of Science ®Google Scholar
• Arnsten, A. F., Wang, M., & Paspalas, C. D. (2015). Dopamine's actions in primate prefrontal cortex: Challenges for treating cognitive disorders. Pharmacological Reviews, 67(3), 681–696. doi:10.1124/pr.115.010512
   PubMed Web of Science ®Google Scholar
• Attwood, A. S., O'Sullivan, H., Leonards, U., Mackintosh, B., & Munafo, M. R. (2008). Attentional bias training and cue reactivity in cigarette smokers. Addiction, 103(11), 1875–1882. doi:10.1111/j.1360-0443.2008.02335.x
   PubMed Web of Science ®Google Scholar
• Bates, M. E., Buckman, J. F., & Nguyen, T. T. (2013). A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders. Neuropsychology Review, 23(1), 27–47. doi:10.1007/s11065-013-9228-3
   PubMed Web of Science ®Google Scholar
• Bates, M. E., Pawlak, A. P., Tonigan, J. S., & Buckman, J. F. (2006). Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change. Psychology of Addictive Behaviors, 20(3), 241–253. doi:10.1037/0893-164X.20.3.241
   PubMed Web of Science ®Google Scholar
• Beard, C., Sawyer, A. T., & Hofmann, S. G. (2012). Efficacy of attention bias modification using threat and appetitive stimuli: A meta-analytic review. Behavior Therapy, 43(4), 724–740. doi:10.1016/j.beth.2012.01.002
   PubMed Web of Science ®Google Scholar
• Bickel, W. K., Yi, R., Landes, R. D., Hill, P. F., & Baxter, C. (2011). Remember the future: Working memory training decreases delay discounting among stimulant addicts. Biological Psychiatry, 69(3), 260–265. doi:10.1016/j.biopsych.2010.08.017
   PubMed Web of Science ®Google Scholar
• Bora, E., Yucel, M., & Pantelis, C. (2010). Cognitive impairment in schizophrenia and affective psychoses: Implications for DSM-V criteria and beyond. Schizophrenia Bulletin, 36(1), 36–42. doi:10.1093/schbul/sbp094
   PubMed Web of Science ®Google Scholar
• Bourne, C., Aydemir, O., Balanza-Martinez, V., Bora, E., Brissos, S., Cavanagh, J. T., ... Goodwin, G. M. (2013). Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: An individual patient data meta-analysis. Acta Psychiatria Scandinavica, 128(3), 149–162. doi:10.1111/acps.12133
   PubMed Web of Science ®Google Scholar
• Bowie, C. R., Gupta, M., & Holshausen, K. (2013). Cognitive remediation therapy for mood disorders: Rationale, early evidence, and future directions. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 58(6), 319–325.
   PubMed Web of Science ®Google Scholar
• Bowie, C. R., Gupta, M., Holshausen, K., Jokic, R., Best, M., & Milev, R. (2013). Cognitive remediation for treatment-resistant depression: Effects on cognition and functioning and the role of online homework. Journal of Nervous and Mental Disease, 201(8), 680–685. doi:10.1097/NMD.0b013e31829c5030
   PubMed Web of Science ®Google Scholar
• Bradizza, C. M., Stasiewicz, P. R., & Dermen, K. H. (2014). Behavioral interventions for individuals dually-diagnosed with a severe mental illness and a substance use disorder. Current Addictiction Reports, 1(4), 243–250. doi:10.1007/s40429-014-0032-9
   PubMedGoogle Scholar
• Brewer, J. A., Worhunsky, P. D., Carroll, K. M., Rounsaville, B. J., & Potenza, M. N. (2008). Pretreatment brain activation during stroop task is associated with outcomes in cocaine-dependent patients. Biological Psychiatry, 64(11), 998–1004. doi:10.1016/j.biopsych.2008.05.024
   PubMed Web of Science ®Google Scholar
• Browning, M., Holmes, E. A., & Harmer, C. J. (2010). The modification of attentional bias to emotional information: A review of the techniques, mechanisms, and relevance to emotional disorders. Cognitive, Affective & Behavioral Neuroscience, 10(1), 8–20. doi:10.3758/CABN.10.1.8
   PubMed Web of Science ®Google Scholar
• Buchanan, R. W., Conley, R. R., Dickinson, D., Ball, M. P., Feldman, S., Gold, J. M., & McMahon, R. P. (2008). Galantamine for the treatment of cognitive impairments in people with schizophrenia. American Journal of Psychiatry, 165(1), 82–89. doi:10.1176/appi.ajp.2007.07050724
   PubMed Web of Science ®Google Scholar
• Buchanan, R. W., Davis, M., Goff, D., Green, M. F., Keefe, R. S., Leon, A. C., … Stover, E. (2005). A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophrenia Bulletin, 31(1), 5–19.
   PubMed Web of Science ®Google Scholar
• Carroll, K. M., Kiluk, B. D., Nich, C., Gordon, M. A., Portnoy, G. A., Marino, D. R., & Ball, S. A. (2014). Computer-assisted delivery of cognitive-behavioral therapy: Efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone. American Journal of Psychiatry, 171(4), 436–444. doi:10.1176/appi.ajp.2013.13070987
   PubMed Web of Science ®Google Scholar
• Carroll, K. M., Power, M. E., Bryant, K., & Rounsaville, B. J. (1993). One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. Journal of Nervous and Mental Disease, 181(2), 71–79. doi:10.1097/00005053-199302000-00001
   PubMed Web of Science ®Google Scholar
• Chambers, C. D., Garavan, H., & Bellgrove, M. A. (2009). Insights into the neural basis of response inhibition from cognitive and clinical neuroscience. Neuroscience and Biobehavioral Reviews, 33(5), 631–646. doi:10.1097/00005053-199302000-00001
   PubMed Web of Science ®Google Scholar
• Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: L. Erlbaum Associates.
   Google Scholar
• Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 67(2), 247–257. doi:10.4088/JCP.v67n0211
   PubMed Web of Science ®Google Scholar
• Cox, W. M., Fadardi, J. S., Intriligator, J. M., & Klinger, E. (2014). Attentional bias modification for addictive behaviors: Clinical implications. CNS Spectrums, 19(3), 215–224. doi:10.1017/S1092852914000091
   PubMed Web of Science ®Google Scholar
• Cristea, I. A., Kok, R. N., & Cuijpers, P. (2015). Efficacy of cognitive bias modification interventions in anxiety and depression: Meta-analysis. British Journal of Psychiatry, 206(1), 7–16. doi:10.1192/bjp.bp.114.146761
   PubMed Web of Science ®Google Scholar
• Cuthbert, B. N., & Insel, T. R. (2013). Toward the future of psychiatric diagnosis: The seven pillars of RDoC. BMC Medicine, 11, 126. doi:10.1186/1741-7015-11-126
   PubMed Web of Science ®Google Scholar
• Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005). A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology, 30(1), 205–211. doi:10.1038/sj.npp.1300600
   PubMed Web of Science ®Google Scholar
• Dackis, C. A., Kampman, K. M., Lynch, K. G., Plebani, J. G., Pettinati, H. M., Sparkman, T., & O'Brien, C. P. (2012). A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Journal of Substance Abuse Treatment, 43(3), 303–312. doi:10.1016/j.jsat.2011.12.014
   PubMed Web of Science ®Google Scholar
• De La Garza, R., 2nd, Newton, T. F., Haile, C. N., Yoon, J. H., Nerumalla, C. S., Mahoney, J. J., 3rd, & Aziziyeh, A. (2012). Rivastigmine reduces “likely to use methamphetamine” in methamphetamine-dependent volunteers. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 37(1), 141–146. doi:10.1016/j.pnpbp.2011.12.014
   PubMed Web of Science ®Google Scholar
• de Wit, H. (2009). Impulsivity as a determinant and consequence of drug use: A review of underlying processes. Addiction Biology, 14(1), 22–31. doi:10.1111/j.1369-1600.2008.00129.x
   PubMed Web of Science ®Google Scholar
• Dean, A. C., London, E. D., Sugar, C. A., Kitchen, C. M., Swanson, A. N., Heinzerling, K. G., … Shoptaw, S. (2009). Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables. Drug and Alcohol Dependence, 105(1–2), 48–55. doi:10.1016/j.drugalcdep.2009.06.008
   PubMed Web of Science ®Google Scholar
• Demant, K. M., Vinberg, M., Kessing, L. V., & Miskowiak, K. W. (2015). Effects of short-term cognitive remediation on cognitive dysfunction in partially or fully remitted individuals with bipolar disorder: Results of a randomised controlled trial. PloS One, 10(6), e0127955. doi:10.1371/journal.pone.0127955
   Google Scholar
• Deutsch, S. I., Schwartz, B. L., Schooler, N. R., Brown, C. H., Rosse, R. B., & Rosse, S. M. (2013). Targeting alpha-7 nicotinic neurotransmission in schizophrenia: A novel agonist strategy. Schizophrenia Research, 148(1–3), 138–144. doi:10.1016/j.schres.2013.05.023
   PubMed Web of Science ®Google Scholar
• DeVito, E. E., Blackwell, A. D., Clark, L., Kent, L., Dezsery, A. M., Turner, D. C., … Sahakian, B. J. (2009). Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD). Psychopharmacology, 202(1-3), 531–539. doi:10.1007/s00213-008-1337-y
   PubMed Web of Science ®Google Scholar
• DeVito, E. E., Blackwell, A. D., Kent, L., Ersche, K. D., Clark, L., Salmond, C. H., … Sahakian, B. J. (2008). The effects of methylphenidate on decision making in attention-deficit/hyperactivity disorder. Biological Psychiatry, 64(7), 636–639. doi:10.1016/j.biopsych.2008.04.017
   PubMed Web of Science ®Google Scholar
• Dursteler, K. M., Berger, E. M., Strasser, J., Caflisch, C., Mutschler, J., Herdener, M., & Vogel, M. (2015). Clinical potential of methylphenidate in the treatment of cocaine addiction: A review of the current evidence. Substance Abuse and Rehabilitation, 6, 61–74. doi:10.2147/SAR.S50807
   PubMed Web of Science ®Google Scholar
• Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008). A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry, 165(2), 179–187. doi:10.1176/appi.ajp.2007.06111851
   PubMed Web of Science ®Google Scholar
• Dyer, M. A., Freudenreich, O., Culhane, M. A., Pachas, G. N., Deckersbach, T., Murphy, E., … Evins, A. E. (2008). High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia. Schizophrenia Research, 102(1–3), 88–95. doi:10.1016/j.schres.2007.12.491
   PubMed Web of Science ®Google Scholar
• Eagle, D. M., Bari, A., & Robbins, T. W. (2008). The neuropsychopharmacology of action inhibition: Cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology, 199(3), 439–456. doi:10.1007/s00213-008-1127-6
   PubMed Web of Science ®Google Scholar
• Elliott, M., & Parente, F. (2014). Efficacy of memory rehabilitation therapy: A meta-analysis of TBI and stroke cognitive rehabilitation literature. Brain Injury, 28(12), 1610–1616. doi:10.3109/02699052.2014.934921
   PubMed Web of Science ®Google Scholar
• Ersche, K. D., Jones, P. S., Williams, G. B., Turton, A. J., Robbins, T. W., & Bullmore, E. T. (2012). Abnormal brain structure implicated in stimulant drug addiction. Science, 335(6068), 601–604. doi:10.1126/science.1214463
   PubMed Web of Science ®Google Scholar
• Field, M., & Cox, W. M. (2008). Attentional bias in addictive behaviors: A review of its development, causes, and consequences. Drug and Alcohol Dependence, 97(1–2), 1–20. doi:10.1016/j.drugalcdep.2008.03.030
   PubMed Web of Science ®Google Scholar
• Field, M., Munafo, M. R., & Franken, I. H. (2009). A meta-analytic investigation of the relationship between attentional bias and subjective craving in substance abuse. Psychological Bulletin, 135(4), 589–607. doi:10.1037/a0015843
   PubMed Web of Science ®Google Scholar
• Fioravanti, M., Bianchi, V., & Cinti, M. E. (2012). Cognitive deficits in schizophrenia: An updated metanalysis of the scientific evidence. BMC Psychiatry, 12, 64. doi:10.1186/1471-244x-12-64
   PubMed Web of Science ®Google Scholar
• Forray, A., & Sofuoglu, M. (2014). Future pharmacological treatments for substance use disorders. British Journal of Clinical Pharmacology, 77(2), 382–400. doi:10.1111/j.1365-2125.2012.04474.x
   PubMed Web of Science ®Google Scholar
• Friedman, N. P., Miyake, A., Young, S. E., Defries, J. C., Corley, R. P., & Hewitt, J. K. (2008). Individual differences in executive functions are almost entirely genetic in origin. Journal of Experimental Psychology: General, 137(2), 201–225. doi:10.1037/0096-3445.137.2.201
   PubMed Web of Science ®Google Scholar
• Galloway, G. P., Singleton, E. G., & The Methamphetamine Treatment Project Corporate. (2009). How long does craving predict use of methamphetamine? Assessment of use one to seven weeks after the assessment of craving: Craving and ongoing methamphetamine use. Substance Abuse, 1, 63–79.
   PubMedGoogle Scholar
• Ghahremani, D. G., Tabibnia, G., Monterosso, J., Hellemann, G., Poldrack, R. A., & London, E. D. (2011). Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. Neuropsychopharmacology, 36(5), 950–959. doi:10.1038/npp.2010.233
   PubMed Web of Science ®Google Scholar
• Goldstein, R. Z., Woicik, P. A., Maloney, T., Tomasi, D., Alia-Klein, N., Shan, J., … Volkow, N. D. (2010). Oral methylphenidate normalizes cingulate activity in cocaine addiction during a salient cognitive task. Proceedings of the National Academy of Sciences of the United States of America, 107(38), 16667–16672. doi:10.1073/pnas.1011455107
   PubMed Web of Science ®Google Scholar
• Goschke, T. (2014). Dysfunctions of decision-making and cognitive control as transdiagnostic mechanisms of mental disorders: Advances, gaps, and needs in current research. International Journal of Methods in Psychiatric Research, 23 Suppl 1, 41–57. doi:10.1002/mpr.1410
   PubMed Web of Science ®Google Scholar
• Goss, A. J., Kaser, M., Costafreda, S. G., Sahakian, B. J., & Fu, C. H. (2013). Modafinil augmentation therapy in unipolar and bipolar depression: A systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Psychiatry, 74(11), 1101–1107. doi:10.4088/JCP.13r08560
   PubMed Web of Science ®Google Scholar
• Hakamata, Y., Lissek, S., Bar-Haim, Y., Britton, J. C., Fox, N. A., Leibenluft, E., … Pine, D. S. (2010). Attention bias modification treatment: A meta-analysis toward the establishment of novel treatment for anxiety. Biological Psychiatry, 68(11), 982–990. doi:10.1016/j.biopsych.2010.07.021
   PubMed Web of Science ®Google Scholar
• Hallion, L. S., & Ruscio, A. M. (2011). A meta-analysis of the effect of cognitive bias modification on anxiety and depression. Psychological Bulletin, 137(6), 940–958. doi:10.1037/a0024355
   PubMed Web of Science ®Google Scholar
• Hasselbalch, B. J., Knorr, U., & Kessing, L. V. (2011). Cognitive impairment in the remitted state of unipolar depressive disorder: A systematic review. Journal of Affective Disorders, 134(1–3), 20–31. doi:10.1016/j.jad.2010.11.011
   PubMed Web of Science ®Google Scholar
• Herbeck, D. M., Brecht, M. L., & Lovinger, K. (2015). Mortality, causes of death, and health status among methamphetamine users. Journal of Addictive Diseases, 34(1), 88–100. doi:10.1080/10550887.2014.975610
   PubMed Web of Science ®Google Scholar
• Hester, R., Lee, N., Pennay, A., Nielsen, S., & Ferris, J. (2010). The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence. Experimental and Clinical Psychopharmacology, 18(6), 489–497. doi:10.1037/a0021791
   PubMed Web of Science ®Google Scholar
• Hofmann, S. G., Asnaani, A., Vonk, I. J., Sawyer, A. T., & Fang, A. (2012). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research, 36(5), 427–440. doi:10.1007/s10608-012-9476-1
   PubMed Web of Science ®Google Scholar
• Howe, W. M., Berry, A. S., Francois, J., Gilmour, G., Carp, J. M., Tricklebank, M., … Sarter, M. (2013). Prefrontal cholinergic mechanisms instigating shifts from monitoring for cues to cue-guided performance: Converging electrochemical and fMRI evidence from rats and humans. Journal of Neuroscience, 33(20), 8742–8752. doi:10.1523/JNEUROSCI.5809-12.2013
   PubMed Web of Science ®Google Scholar
• Irani, F., Kalkstein, S., Moberg, E. A., & Moberg, P. J. (2011). Neuropsychological performance in older patients with schizophrenia: A meta-analysis of cross-sectional and longitudinal studies. Schizophrenia Bulletin, 37(6), 1318–1326. doi:10.1093/schbul/sbq057
   PubMed Web of Science ®Google Scholar
• Jovanovski, D., Erb, S., & Zakzanis, K. K. (2005). Neurocognitive deficits in cocaine users: A quantitative review of the evidence. Journal of Clinical and Experimental Neuropsychology, 27(2), 189–204. doi:10.1080/13803390490515694
   PubMed Web of Science ®Google Scholar
• Kahneman, D. (2011). Thinking, fast and slow. New York, NY: Macmillan.
   Google Scholar
• Kalechstein, A. D., De La Garza, R., 2nd, & Newton, T. F. (2010). Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment. American Journal on Addictions, 19(4), 340–344. doi:10.1111/j.1521-0391.2010.00052.x
   PubMed Web of Science ®Google Scholar
• Kalechstein, A. D., Mahoney, J. J., 3rd, Yoon, J. H., Bennett, R., & De la Garza, R., 2nd. (2013). Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users. Neuropharmacology, 64, 472–478. doi:10.1016/j.neuropharm.2012.06.064
   PubMed Web of Science ®Google Scholar
• Kerst, W. F., & Waters, A. J. (2014). Attentional retraining administered in the field reduces smokers' attentional bias and craving. Health Psychology, 33(10), 1232–1240. doi:10.1037/a0035708
   PubMed Web of Science ®Google Scholar
• Keshavan, M. S., Vinogradov, S., Rumsey, J., Sherrill, J., & Wagner, A. (2014). Cognitive training in mental disorders: Update and future directions. American Journal of Psychiatry, 171(5), 510–522. doi:10.1176/appi.ajp.2013.13081075
   PubMed Web of Science ®Google Scholar
• Kim, Y. W., Kim, D. Y., Shin, J. C., Park, C. I., & Lee, J. D. (2009). The changes of cortical metabolism associated with the clinical response to donepezil therapy in traumatic brain injury. Clinical Neuropharmacology, 32(2), 63–68. doi:10.1097/WNF.0B013E31816F1BC1
   PubMed Web of Science ®Google Scholar
• Kuckertz, J. M., Amir, N., Boffa, J. W., Warren, C. K., Rindt, S. E., Norman, S., … McLay, R. (2014). The effectiveness of an attention bias modification program as an adjunctive treatment for post-traumatic stress disorder. Behaviour Research and Therapy, 63, 25–35. doi 10.1016/j.brat.2014.09.002
   PubMed Web of Science ®Google Scholar
• Lee, N., Pennay, A., Hester, R., McKetin, R., Nielsen, S., & Ferris, J. (2013). A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: Feasibility, tolerability and clinical outcomes. Drug and Alcohol Review, 32(1), 88–95. doi:10.1111/j.1465-3362.2012.00473.x
   PubMed Web of Science ®Google Scholar
• Leeman, R. F., Robinson, C. D., Waters, A. J., & Sofuoglu, M. (2014). A critical review of the literature on attentional bias in cocaine use disorder and suggestions for future research. Experimental and Clinical Psychopharmacology, 22(6), 469–483. doi:10.1037/a0037806
   PubMed Web of Science ®Google Scholar
• Leifker, F. R., Patterson, T. L., Bowie, C. R., Mausbach, B. T., & Harvey, P. D. (2010). Psychometric properties of performance-based measurements of functional capacity: Test-retest reliability, practice effects, and potential sensitivity to change. Schizophrenia Research, 119(1–3), 246–252. doi:10.1016/j.schres.2010.03.021
   PubMed Web of Science ®Google Scholar
• Levin, F. R., Evans, S. M., Brooks, D. J., & Garawi, F. (2007). Treatment of cocaine dependent treatment seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo. Drug and Alcohol Dependence, 87(1), 20–29. doi:10.1016/j.drugalcdep.2006.07.004
   PubMed Web of Science ®Google Scholar
• Li, C. S., Morgan, P. T., Matuskey, D., Abdelghany, O., Luo, X., Chang, J. L., … Malison, R. T. (2010). Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients. Proceedings of the National Academy of Sciences of the United States of America, 107(32), 14455–14459. doi:10.1073/pnas.1002467107
   PubMed Web of Science ®Google Scholar
• Lindenmayer, J. P., & Khan, A. (2011). Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia. Schizophrenia Research, 125(2–3), 267–277. doi:10.1016/j.schres.2010.08.021
   PubMed Web of Science ®Google Scholar
• Lohr, J. B., Liu, L., Caligiuri, M. P., Kash, T. P., May, T. A., Murphy, J. D., & Ancoli-Israel, S. (2013). Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: A randomized, double-blind, placebo-controlled study. Schizophrenia Research, 150(1), 289–296. doi:10.1016/j.schres.2013.07.039
   PubMed Web of Science ®Google Scholar
• MacLeod, C., Rutherford, E., Campbell, L., Ebsworthy, G., & Holker, L. (2002). Selective attention and emotional vulnerability: Assessing the causal basis of their association through the experimental manipulation of attentional bias. Journal of Abnormal Psychology, 111(1), 107–123. doi:10.1037/0021-843X.111.1.107
   PubMed Web of Science ®Google Scholar
• Mahoney, J. J., 3rd, Kalechstein, A. D., Verrico, C. D., Arnoudse, N. M., Shapiro, B. A., & De La Garza, R., 2nd. (2014). Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 50, 137–142, 309, 200–213. doi:10.1016/j.pnpbp.2013.11.001
   PubMed Web of Science ®Google Scholar
• Malykhin, N. V., & Coupland, N. J. (2015). Hippocampal neuroplasticity in major depressive disorder. Neuroscience. doi:10.1016/j.neuroscience.2015.04.047
   PubMed Web of Science ®Google Scholar
• Mark, G. P., Shabani, S., Dobbs, L. K., & Hansen, S. T. (2011). Cholinergic modulation of mesolimbic dopamine function and reward. Physiology and Behavior, 104(1), 76–81. doi:10.1016/j.physbeh.2011.04.052
   PubMed Web of Science ®Google Scholar
• Mereu, M., Bonci, A., Newman, A. H., & Tanda, G. (2013). The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology, 229(3), 415–434. doi:10.1007/s00213-013-3232-4
   PubMed Web of Science ®Google Scholar
• Meusel, L. A., Hall, G. B., Fougere, P., McKinnon, M. C., & MacQueen, G. M. (2013). Neural correlates of cognitive remediation in patients with mood disorders. Psychiatry Research, 214(2), 142–152. doi:10.1016/j.pscychresns.2013.06.007
   PubMed Web of Science ®Google Scholar
• Millan, M. J., Agid, Y., Brune, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., … Young, L. J. (2012). Cognitive dysfunction in psychiatric disorders: Characteristics, causes and the quest for improved therapy. Nature Reviews: Drug Discovery, 11(2), 141–168. doi:10.1038/nrd3628
   PubMed Web of Science ®Google Scholar
• Mogg, K., & Bradley, B. P. (1998). A cognitive-motivational analysis of anxiety. Behaviour Research and Therapy, 36(9), 809–848. doi:10.1016/S0005-7967(98)00063-1
   PubMed Web of Science ®Google Scholar
• Mogoaşe, C., David, D., & Koster, E. H. (2014). Clinical efficacy of attentional bias modification procedures: An updated meta‐analysis. Journal of Clinical Psychology, 70(12), 1133–1157.
   PubMed Web of Science ®Google Scholar
• Nuechterlein, K. H., Green, M. F., Kern, R. S., Baade, L. E., Barch, D. M., Cohen, J. D., … Marder, S. R. (2008). The MATRICS Consensus Cognitive Battery, part 1: Test selection, reliability, and validity. American Journal of Psychiatry, 165(2), 203–213. doi:10.1176/appi.ajp.2007.07010042
   PubMed Web of Science ®Google Scholar
• Nunes, E. V., & Levin, F. R. (2004). Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. JAMA: The Journal of the American Medical Association, 291(15), 1887–1896. doi:10.1001/jama.291.15.1887
   PubMed Web of Science ®Google Scholar
• Penades, R., Pujol, N., Catalan, R., Massana, G., Rametti, G., Garcia-Rizo, C., … Junque, C. (2013). Brain effects of cognitive remediation therapy in schizophrenia: A structural and functional neuroimaging study. Biological Psychiatry, 73(10), 1015–1023. doi:10.1016/j.biopsych.2013.01.017
   PubMed Web of Science ®Google Scholar
• Poling, J., Kosten, T. R., & Sofuoglu, M. (2007). Treatment outcome predictors for cocaine dependence. American Journal of Drug and Alcohol Abuse, 33(2), 191–206. doi:10.1080/00952990701199416
   PubMed Web of Science ®Google Scholar
• Posner, M. I., & Rothbart, M. K. (1998). Attention, self-regulation and consciousness. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 353(1377), 1915–1927. doi:10.1098/rstb.1998.0344
   PubMed Web of Science ®Google Scholar
• Posner, M. I., Snyder, C. R., & Davidson, B. J. (1980). Attention and the detection of signals. Journal of Experimental Psychology, 109(2), 160–174.
   PubMedGoogle Scholar
• Potvin, S., Stavro, K., Rizkallah, E., & Pelletier, J. (2014). Cocaine and cognition: A systematic quantitative review. Journal of Addiction Medicine, 8(5), 368–376. doi:10.1097/ADM.0000000000000066
   PubMed Web of Science ®Google Scholar
• Reboussin, B. A., & Anthony, J. C. (2006). Is there epidemiological evidence to support the idea that a cocaine dependence syndrome emerges soon after onset of cocaine use? Neuropsychopharmacology, 31(9), 2055–2064. doi:10.1038/sj.npp.1301037
   PubMed Web of Science ®Google Scholar
• Revell, E. R., Neill, J. C., Harte, M., Khan, Z., & Drake, R. J. (2015). A systematic review and meta-analysis of cognitive remediation in early schizophrenia. Schizophrenia Research, 168(1–2), 213–222. doi:10.1016/j.schres.2015.08.017
   PubMed Web of Science ®Google Scholar
• Rock, P. L., Roiser, J. P., Riedel, W. J., & Blackwell, A. D. (2014). Cognitive impairment in depression: A systematic review and meta-analysis. Psychological Medicine, 44(10), 2029–2040. doi:10.1017/s0033291713002535
   PubMed Web of Science ®Google Scholar
• Rounsaville, B. J., Anton, S. F., Carroll, K., Budde, D., Prusoff, B. A., & Gawin, F. (1991). Psychiatric diagnoses of treatment-seeking cocaine abusers. Archives of General Psychiatry, 48(1), 43–51. doi:10.1001/archpsyc.1991.01810250045005
   PubMed Web of Science ®Google Scholar
• Rueda, M. R., Rothbart, M. K., McCandliss, B. D., Saccomanno, L., & Posner, M. I. (2005). Training, maturation, and genetic influences on the development of executive attention. Proceedings of the National Academy of Sciences of the United States of America, 102(41), 14931–14936. doi:10.1073/pnas.0506897102
   PubMed Web of Science ®Google Scholar
• Salo, R., Flower, K., Kielstein, A., Leamon, M. H., Nordahl, T. E., & Galloway, G. P. (2011). Psychiatric comorbidity in methamphetamine dependence. Psychiatry Research, 186(2–3), 356–361. doi:10.1016/j.psychres.2010.09.014
   PubMed Web of Science ®Google Scholar
• Sarter, M., Lustig, C., Howe, W. M., Gritton, H., & Berry, A. S. (2014). Deterministic functions of cortical acetylcholine. European Journal of Neuroscience, 39(11), 1912–1920. doi:10.1111/ejn.12515
   PubMed Web of Science ®Google Scholar
• Schaefer, J., Giangrande, E., Weinberger, D. R., & Dickinson, D. (2013). The global cognitive impairment in schizophrenia: Consistent over decades and around the world. Schizophrenia Research, 150(1), 42–50. doi:10.1016/j.schres.2013.07.009
   PubMed Web of Science ®Google Scholar
• Schilström, B., Ivanov, V. B., Wiker, C., & Svensson, T. H. (2007). Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors. Neuropsychopharmacology, 32(1), 43–53.
   Google Scholar
• Schoechlin, C., & Engel, R. R. (2005). Neuropsychological performance in adult attention-deficit hyperactivity disorder: Meta-analysis of empirical data. Archives of Clinical Neuropsychology, 20(6), 727–744. doi:10.1016/j.acn.2005.04.005
   PubMed Web of Science ®Google Scholar
• Schoenmakers, T. M., de Bruin, M., Lux, I. F., Goertz, A. G., Van Kerkhof, D. H., & Wiers, R. W. (2010). Clinical effectiveness of attentional bias modification training in abstinent alcoholic patients. Drug and Alcohol Dependence, 109(1–3), 30–36. doi:10.1016/j.drugalcdep.2009.11.022
   PubMed Web of Science ®Google Scholar
• Schubert, M. H., Young, K. A., & Hicks, P. B. (2006). Galantamine improves cognition in schizophrenic patients stabilized on risperidone. Biological Psychiatry, 60(6), 530–533. doi:10.1016/j.biopsych.2006.04.006
   PubMed Web of Science ®Google Scholar
• Schumann, G., Binder, E. B., Holte, A., de Kloet, E. R., Oedegaard, K. J., Robbins, T. W., … Wittchen, H. U. (2014). Stratified medicine for mental disorders. European Neuropsychopharmacology, 24(1), 5–50. doi:10.1016/j.euroneuro.2013.09.010
   PubMed Web of Science ®Google Scholar
• Scott, J. C., Matt, G. E., Wrocklage, K. M., Crnich, C., Jordan, J., Southwick, S. M., … Schweinsburg, B. C. (2015). A quantitative meta-analysis of neurocognitive functioning in posttraumatic stress disorder. Psychological Bulletin, 141(1), 105–140. doi:10.1037/a0038039
   PubMed Web of Science ®Google Scholar
• Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007). Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychology Review, 17(3), 275–297. doi:10.1007/s11065-007-9031-0
   PubMed Web of Science ®Google Scholar
• Sharma, T., Reed, C., Aasen, I., & Kumari, V. (2006). Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: A randomized, placebo-controlled, double-blind investigation. Schizophrenia Research, 85(1–3), 73–83. doi:10.1016/j.schres.2006.03.037
   PubMed Web of Science ®Google Scholar
• Simon, S. L., Dean, A. C., Cordova, X., Monterosso, J. R., & London, E. D. (2010). Methamphetamine dependence and neuropsychological functioning: Evaluating change during early abstinence. Journal of Studies on Alcohol and Drugs, 71(3), 335–344.
   PubMed Web of Science ®Google Scholar
• Sinha, R., Fox, H. C., Hong, K. I., Hansen, J., Tuit, K., & Kreek, M. J. (2011). Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Archives of General Psychiatry, 68(9), 942–952. doi:10.1001/archgenpsychiatry.2011.49
   PubMed Web of Science ®Google Scholar
• Sinha, R., Garcia, M., Paliwal, P., Kreek, M. J., & Rounsaville, B. J. (2006). Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Archives of General Psychiatry, 63(3), 324–331. doi:10.1001/archpsyc.63.3.324
   PubMed Web of Science ®Google Scholar
• Sofuoglu, M. (2010). Cognitive enhancement as a pharmacotherapy target for stimulant addiction. Addiction, 105(1), 38–48. doi:10.1111/j.1360-0443.2009.02791.x
   PubMed Web of Science ®Google Scholar
• Sofuoglu, M., & Carroll, K. M. (2011). Effects of galantamine on cocaine use in chronic cocaine users. American Journal on Addictions, 20(3), 302–303. doi:10.1111/j.1521-0391.2011.00130.x
   PubMed Web of Science ®Google Scholar
• Sofuoglu, M., DeVito, E. E., Waters, A. J., & Carroll, K. M. (2013). Cognitive enhancement as a treatment for drug addictions. Neuropharmacology, 64, 452–463. doi:10.1016/j.neuropharm.2012.06.021
   PubMed Web of Science ®Google Scholar
• Sofuoglu, M., & Mooney, M. (2009). Cholinergic functioning in stimulant addiction: Implications for medications development. CNS Drugs, 23(11), 939–952. doi:10.2165/11310920-000000000-00000
   PubMed Web of Science ®Google Scholar
• Sofuoglu, M., Sugarman, D. E., & Carroll, K. M. (2010). Cognitive function as an emerging treatment target for marijuana addiction. Experimental and Clinical Psychopharmacology, 18(2), 109–119. doi:10.1037/a0019295
   PubMed Web of Science ®Google Scholar
• Sofuoglu, M., Waters, A. J., Poling, J., & Carroll, K. M. (2011). Galantamine improves sustained attention in chronic cocaine users. Experimental and Clinical Psychopharmacology, 19(1), 11–19. doi:10.1037/a0022213
   PubMed Web of Science ®Google Scholar
• Stavro, K., Pelletier, J., & Potvin, S. (2013). Widespread and sustained cognitive deficits in alcoholism: A meta-analysis. Addiction Biology, 18(2), 203–213. doi:10.1111/j.1369-1600.2011.00418.x
   PubMed Web of Science ®Google Scholar
• Stein, M. D. (1999). Medical consequences of substance abuse. Psychiatric Clinics of North America, 22(2), 351–370. doi:10.1016/S0193-953X(05)70081-2
   PubMed Web of Science ®Google Scholar
• Streeter, C. C., Terhune, D. B., Whitfield, T. H., Gruber, S., Sarid-Segal, O., Silveri, M. M., … Yurgelun-Todd, D. A. (2008). Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology, 33(4), 827–836. doi:10.1038/sj.npp.1301465
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2014). Results from the 2013 National Survey on Drug Use and Health: National findings. (HHS Publication No. (SMA) 14-4863). Rockville, MD: Author.
   Google Scholar
• Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005). Mechanisms of neurotransmitter release by amphetamines: A review. Progress in Neurobiology, 75(6), 406–433. doi:10.1016/j.pneurobio.2005.04.003
   PubMed Web of Science ®Google Scholar
• Swendsen, J., & Le Moal, M. (2011). Individual vulnerability to addiction. Annals of the New York Academy of Sciences, 1216, 73–85. doi:10.1111/j.1749-6632.2010.05894.x
   PubMed Web of Science ®Google Scholar
• Tsapakis, E. M., Dimopoulou, T., & Tarazi, F. I. (2015). Clinical management of negative symptoms of schizophrenia: An update. Pharmacology and Therapeutics, 153, 135–147. doi:10.1016/j.pharmthera.2015.06.008
   PubMed Web of Science ®Google Scholar
• Turner, D. C., Blackwell, A. D., Dowson, J. H., McLean, A., & Sahakian, B. J. (2005). Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder. Psychopharmacology, 178(2–3), 286–295. doi:10.1007/s00213-004-1993-5
   PubMed Web of Science ®Google Scholar
• Turner, T. H., LaRowe, S., Horner, M. D., Herron, J., & Malcolm, R. (2009). Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. Journal of Substance Abuse Treatment, 37(4), 328–334. doi:10.1016/j.jsat.2009.03.009
   PubMed Web of Science ®Google Scholar
• Van Bockstaele, B., Verschuere, B., Tibboel, H., De Houwer, J., Crombez, G., & Koster, E. H. (2014). A review of current evidence for the causal impact of attentional bias on fear and anxiety. Psychological Bulletin, 140(3), 682–721. doi:10.1037/a0034834
   PubMed Web of Science ®Google Scholar
• Verdejo-Garcia, A., Betanzos-Espinosa, P., Lozano, O. M., Vergara-Moragues, E., Gonzalez-Saiz, F., Fernandez-Calderon, F., … Perez-Garcia, M. (2012). Self-regulation and treatment retention in cocaine dependent individuals: A longitudinal study. Drug and Alcohol Dependence, 122(1–2), 142–148. doi:10.1016/j.drugalcdep.2011.09.025
   PubMed Web of Science ®Google Scholar
• Vergara-Moragues, E., Gonzalez-Saiz, F., Lozano, O. M., Betanzos Espinosa, P., Fernandez Calderon, F., Bilbao-Acebos, I., … Verdejo Garcia, A. (2012). Psychiatric comorbidity in cocaine users treated in therapeutic community: Substance-induced versus independent disorders. Psychiatry Research, 200(2–3), 734–741. doi:10.1016/j.psychres.2012.07.043
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Franceschi, D., Sedler, M., … Logan, J. (2001). Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. Journal of Neuroscience, 21(23), 9414–9418.
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., Koob, G., & Baler, R. (2015). Biomarkers in substance use disorders. ACS Chem Neurosci, 6(4), 522–525. doi:10.1021/acschemneuro.5b00067
   PubMed Web of Science ®Google Scholar
• Wagner, M., Schulze-Rauschenbach, S., Petrovsky, N., Brinkmeyer, J., von der Goltz, C., Grunder, G., … Winterer, G. (2013). Neurocognitive impairments in non-deprived smokers—results from a population-based multi-center study on smoking-related behavior. Addiction Biology, 18(4), 752–761. doi:10.1111/j.1369-1600.2011.00429.x
   PubMed Web of Science ®Google Scholar
• Wallace, T. L., Ballard, T. M., Pouzet, B., Riedel, W. J., & Wettstein, J. G. (2011). Drug targets for cognitive enhancement in neuropsychiatric disorders. Pharmacology, Biochemistry and Behavior, 99(2), 130–145. doi:10.1016/j.pbb.2011.03.022
   PubMed Web of Science ®Google Scholar
• Weinberger, A. H., & Sofuoglu, M. (2009). The impact of cigarette smoking on stimulant addiction. American Journal of Drug and Alcohol Abuse, 35(1), 12–17. doi:10.1080/00952990802326280
   PubMed Web of Science ®Google Scholar
• Wiers, R. W., Eberl, C., Rinck, M., Becker, E. S., & Lindenmeyer, J. (2011). Retraining automatic action tendencies changes alcoholic patients' approach bias for alcohol and improves treatment outcome. Psychological Science, 22(4), 490–497. doi:10.1177/0956797611400615
   PubMed Web of Science ®Google Scholar
• Wiers, R. W., Gladwin, T. E., Hofmann, W., Salemink, E., & Ridderinkhof, K. R. (2013). Cognitive bias modification and cognitive control training in addiction and related psychopathology mechanisms, clinical perspectives, and ways forward. Clinical Psychological Science, 1(2), 192–212.
   Google Scholar
• Wykes, T., Huddy, V., Cellard, C., McGurk, S. R., & Czobor, P. (2011). A meta-analysis of cognitive remediation for schizophrenia: Methodology and effect sizes. American Journal of Psychiatry, 168(5), 472–485. doi:10.1176/appi.ajp.2010.10060855
   PubMed Web of Science ®Google Scholar